New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 3, 2014
14:27 EDTCRTXCornerstone Therapeutics holders approve merger with Chiesi Farmaceutici S.p.A.
Cornerstone Therapeutics announced that its stockholders have approved, at a special stockholder meeting held earlier, the previously announced merger agreement, under which Chiesi Farmaceutici S.p.A. will acquire all of the outstanding common shares of Cornerstone for $9.50 per share in cash. The transaction is expected to close later this afternoon.
News For CRTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for CRTX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use